New Light-Based scanner aims to spot skin cancer more clearly

NCT ID NCT07201376

Recruiting now Diagnosis Sponsor: Dartmouth-Hitchcock Medical Center Source: ClinicalTrials.gov ↗

Summary

This study is testing a new, non-invasive imaging device designed to help doctors tell the difference between harmless skin growths and non-melanoma skin cancers. The device uses a special light to measure oxygen levels in skin tissue, as low oxygen can be a sign of cancer. The goal is to improve diagnosis and help surgeons better define tumor borders before removal.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-MELANOMA SKIN CANCER (NMSC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dartmouth Hitchcock
RECRUITING

Lebanon, New Hampshire, 03766, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

BENIGN SKIN GROWTH NON-MELANOMA SKIN CANCER (NMSC)